MicroRNA-674-5p/5-LO axis involved in autoimmune reaction of Concanavalin A-induced acute mouse liver injury
•Cysteinyl-leukotrienes accumulated during Concanavalin A-induced mouse liver injury.•5-LO upregulation triggered the autoimmune reaction after Concanavalin A challenge.•Seven upregulated and two downregulated miRs were found related to hepatotoxicity of Concanavalin A.•MiR-674-5p negatively regulat...
Saved in:
Published in | Toxicology letters Vol. 258; pp. 101 - 107 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
06.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •Cysteinyl-leukotrienes accumulated during Concanavalin A-induced mouse liver injury.•5-LO upregulation triggered the autoimmune reaction after Concanavalin A challenge.•Seven upregulated and two downregulated miRs were found related to hepatotoxicity of Concanavalin A.•MiR-674-5p negatively regulated 5-LO in hepatic cells with IL-6 or TNF-α presence.
Autoimmune hepatitis is characterized, in part, by the pathways involving cysteinyl-leukotriene metabolites of arachidonic acid, the dynamics of which remain unclear. Here, we explored post-transcriptional regulation in the 5-lipoxygenase (5-LO) pathway of arachidonic acid in a Concanavalin A (Con A) induced mouse model. We found that Con A administration lead to 5-LO overexpression and cysteinyl-leukotriene release in early hepatic injury, which was attenuated by cyclosporin A pretreatment. Subsequent microarray and qRT-PCR analysis further showed that microRNA-674-5p (miR-674-5p) displayed a significant decrease in expression in Con A-damaged liver. Noting that miR-674-5p harbors a potential binding region for 5-LO, we further transfected hepatic cell lines with overexpressing miR-674-5p mimic and discovered a negative regulating effect of miR-674-5p on 5-LO expression in the presence of IL-6 or TNF-α. These findings suggest that miR-674-5p might be a negative regulator in 5-LO mediated autoimmune liver injury, representing a compelling avenue towards future therapeutic interventions. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0378-4274 1879-3169 |
DOI: | 10.1016/j.toxlet.2016.06.010 |